{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:12:58Z","timestamp":1789953178334,"version":"4.0.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1097\/mnm.0b013e32834199e7","type":"journal-article","created":{"date-parts":[[2010,11,17]],"date-time":"2010-11-17T08:15:42Z","timestamp":1289981742000},"page":"106-112","source":"Crossref","is-referenced-by-count":43,"title":["The role of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiating between benign and malignant adrenal lesions"],"prefix":"10.1097","volume":"32","author":[{"given":"Pelin","family":"Ozcan Kara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylan","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonca","family":"Kara Gedik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Ceylan Gunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oktay","family":"Sari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210212","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0033-8389(22)00684-4","article-title":"The incidental adrenal mass.","volume":"34","author":"Korobkin","year":"1996","journal-title":"Radiol Clin North Am"},{"key":"R2-4-20210212","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2214\/ajr.171.1.9648789","article-title":"Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature.","volume":"171","author":"Boland","year":"1998","journal-title":"AJR"},{"key":"R3-4-20210212","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2004-1627","article-title":"Clinical utility of noncontrast computed tomography attenuation value (Hounsfield units) to differentiate adrenal adenomashyperplasias from nonadenomas: cleveland clinic experience.","volume":"90","author":"Hamrahian","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-4-20210212","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1148\/radiology.179.2.2014283","article-title":"Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis.","volume":"179","author":"Lee","year":"1991","journal-title":"Radiology"},{"key":"R5-4-20210212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12149-009-0246-4","article-title":"Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomographycomputed tomography (FDG PETCT) in differentiating between benign and malignant lesions.","volume":"23","author":"Okada","year":"2009","journal-title":"Ann Nucl Med"},{"key":"R6-4-20210212","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R7-4-20210212","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R8-4-20210212","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1007\/s00259-008-0849-3","article-title":"Does (18)F-FDG PETCT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours.","volume":"35","author":"Tessonnier","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-4-20210212","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2214\/AJR.07.3447","article-title":"Utility of PETCT in differentiating benign from malignant adrenal nodules in patients with cancer.","volume":"191","author":"Vikram","year":"2008","journal-title":"AJR"},{"key":"R10-4-20210212","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1200\/JCO.1991.9.8.1462","article-title":"Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer.","volume":"9","author":"Ettinghausen","year":"1991","journal-title":"J Clin Oncol"},{"key":"R11-4-20210212","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2214\/ajr.144.1.67","article-title":"CT-guided adrenal biopsy: accuracy, safety and indications.","volume":"144","author":"Bernardino","year":"1985","journal-title":"AJR"},{"key":"R12-4-20210212","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiology.187.3.8497619","article-title":"Predictive value of image-guided adrenal biopsy: analysis of results of 101 biopsies.","volume":"187","author":"Silverman","year":"1993","journal-title":"Radiology"},{"key":"R13-4-20210212","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1148\/radiology.193.2.7972740","article-title":"Percutaneous adrenal biopsy: review of a 10-year experience.","volume":"193","author":"Welch","year":"1994","journal-title":"Radiology"},{"key":"R14-4-20210212","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1148\/radiology.194.1.7997539","article-title":"Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-F-18-fluoro-2-deoxy-D-glucose.","volume":"194","author":"Boland","year":"1995","journal-title":"Radiology"},{"key":"R15-4-20210212","doi-asserted-by":"crossref","first-page":"W179","DOI":"10.2214\/AJR.09.2891","article-title":"Utility of diffusion-weighted MRI in characterization of adrenal lesions.","volume":"194","author":"Miller","year":"2010","journal-title":"AJR"},{"key":"R16-4-20210212","first-page":"1795","article-title":"18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.","volume":"42","author":"Yun","year":"2001","journal-title":"J Nucl Med"},{"key":"R17-4-20210212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2214\/ajr.173.1.10397094","article-title":"Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions.","volume":"173","author":"Maurea","year":"1999","journal-title":"AJR"},{"key":"R18-4-20210212","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2214\/ajr.168.5.9129444","article-title":"Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-FDG PET.","volume":"168","author":"Erasmus","year":"1997","journal-title":"AJR"},{"key":"R19-4-20210212","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3816\/CLC.2001.n.019","article-title":"Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer.","volume":"3","author":"Gupta","year":"2001","journal-title":"Clin Lung Cancer"},{"key":"R20-4-20210212","first-page":"2058","article-title":"18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer.","volume":"45","author":"Kumar","year":"2004","journal-title":"J Nucl Med"},{"key":"R21-4-20210212","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.acra.2007.01.009","article-title":"Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PETCT: quantitative and qualitative evaluation.","volume":"14","author":"Caoili","year":"2007","journal-title":"Acad Radiol"},{"key":"R22-4-20210212","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2214\/ajr.182.4.1821033","article-title":"Changing role of imaging-guided percutaneous biopsy of adrenal masses: evaluation of 50 adrenal biopsies.","volume":"182","author":"Paulsen","year":"2004","journal-title":"AJR"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006231-201102000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T06:43:53Z","timestamp":1685861033000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201102000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e32834199e7","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}